About SereNeuro Therapeutics
SereNeuro Therapeutics is a preclinical biotech developing therapies to relieve pain without opioids, including an iPSC-derived cell therapy for osteoarthritis joint pain and a gene therapy approach for trigeminal neuralgia. Based at FastForward 1812 in Baltimore, it received a $399,575 Maryland Stem Cell Research Fund Commercialization award in September 2026.